127 related articles for article (PubMed ID: 1439632)
1. Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study.
Akesson A; Blom-Bülow B; Scheja A; Wollmer P; Valind S; Wollheim FA
Scand J Rheumatol; 1992; 21(5):238-44. PubMed ID: 1439632
[TBL] [Abstract][Full Text] [Related]
2. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
Jimenez SA; Sigal SH
J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
[TBL] [Abstract][Full Text] [Related]
3. Cyclofenil versus placebo in progressive systemic sclerosis. A one-year double-blind crossover study of 27 patients.
Blom-Bülow B; Oberg K; Wollheim FA; Persson B; Jonson B; Malmberg P; Boström H; Herbai G
Acta Med Scand; 1981; 210(5):419-28. PubMed ID: 7039242
[TBL] [Abstract][Full Text] [Related]
4. Cyclofenil in the treatment of scleroderma - a general view on the results after treating 29 cases.
Bülow BB; Boström H; Herbai G; Persson B; Wollheim F; Oberg K
Z Rheumatol; 1980; 39(1-2):1-8. PubMed ID: 7424193
[TBL] [Abstract][Full Text] [Related]
5. Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome.
Herbai G
Acta Med Acad Sci Hung; 1978; 35(3-4):201-11. PubMed ID: 756110
[TBL] [Abstract][Full Text] [Related]
6. Improvement of lung function in a scleroderma patient treated for 12 months with cyclofenil.
Blom-Bülow B; Fridriksson H; Herbai G
Ups J Med Sci; 1980; 85(1):67-73. PubMed ID: 7385461
[TBL] [Abstract][Full Text] [Related]
7. Penicillamine in systemic sclerosis: a reappraisal.
Sattar MA; Guindi RT; Sugathan TN
Clin Rheumatol; 1990 Dec; 9(4):517-22. PubMed ID: 2088649
[TBL] [Abstract][Full Text] [Related]
8. The effect of D-penicillamine on pulmonary findings in systemic sclerosis.
Steen VD; Owens GR; Redmond C; Rodnan GP; Medsger TA
Arthritis Rheum; 1985 Aug; 28(8):882-8. PubMed ID: 4026885
[TBL] [Abstract][Full Text] [Related]
9. Treatment of progressive systemic sclerosis with a synthetic weak estrogen: cyclofenil (Sexovid). Report of a case.
Herbai G
Acta Med Scand; 1974 Dec; 196(6):537-40. PubMed ID: 4456988
[No Abstract] [Full Text] [Related]
10. Treatment of progressive systemic sclerosis (scleroderma, PSS) with a new drug influencing connective tissue.
Herbai G; Blom B; Boström H
Acta Med Scand; 1977; 201(3):203-6. PubMed ID: 848357
[TBL] [Abstract][Full Text] [Related]
11. Cyclofenil treatment of scleroderma--a controlled study.
Gibson T; Grahame R
Br J Rheumatol; 1983 Nov; 22(4):218-23. PubMed ID: 6360282
[TBL] [Abstract][Full Text] [Related]
12. Nodular scleroderma in systemic sclerosis under D-penicillamine therapy.
Sasaki T; Denpo K; Ono H; Nakajima H
J Dermatol; 1992 Dec; 19(12):968-71. PubMed ID: 1293190
[TBL] [Abstract][Full Text] [Related]
13. Treatment of progressive systemic sclerosis (PSS) with cyclofenil.
Corrocher R; Morittu L; Bambara LM; De Sandre G
Clin Exp Rheumatol; 1983; 1(4):359-60. PubMed ID: 6681154
[No Abstract] [Full Text] [Related]
14. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
Bluestone R; Grahame R; Holloway V; Holt PJ
Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411
[No Abstract] [Full Text] [Related]
15. Hepatic reactions to cyclofenil.
Olsson R; Tyllström J; Zettergren L
Gut; 1983 Mar; 24(3):260-3. PubMed ID: 6826112
[TBL] [Abstract][Full Text] [Related]
16. The progress of oesophageal involvement in progressive systemic sclerosis during D-penicillamine treatment.
Hendel L; Stentoft P; Aggestrup S
Scand J Rheumatol; 1989; 18(3):149-55. PubMed ID: 2772562
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
Scheja A; Akesson A; Hørslev-Petersen K
Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
[TBL] [Abstract][Full Text] [Related]
18. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
19. Progressive systemic sclerosis and penicillamine.
Rodnan GP
J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
[TBL] [Abstract][Full Text] [Related]
20. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.
Steen VD; Medsger TA; Rodnan GP
Ann Intern Med; 1982 Nov; 97(5):652-9. PubMed ID: 7137731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
